Shanghai Historical Cash Flow

603579 Stock   14.86  0.22  1.50%   
Analysis of Shanghai Rongtai cash flow over time is an excellent tool to project Shanghai Rongtai Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 71.3 M or Capital Expenditures of 103.2 M as it is a great indicator of Shanghai Rongtai ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Shanghai Rongtai Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shanghai Rongtai Health is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Rongtai Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Shanghai Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Shanghai balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shanghai's non-liquid assets can be easily converted into cash.

Shanghai Rongtai Cash Flow Chart

At present, Shanghai Rongtai's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Capital Expenditures is expected to grow to about 103.2 M, whereas Other Cashflows From Financing Activities is forecasted to decline to (1.8 M).

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Shanghai Rongtai Health to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Shanghai Rongtai operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Shanghai Rongtai Health financial statement analysis. It represents the amount of money remaining after all of Shanghai Rongtai Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Shanghai Rongtai's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Shanghai Rongtai Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Rongtai Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Shanghai Rongtai's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Capital Expenditures is expected to grow to about 103.2 M, whereas Other Cashflows From Financing Activities is forecasted to decline to (1.8 M).
 2021 2022 2023 2024 (projected)
Capital Expenditures141.5M100.7M89.6M103.2M
Dividends Paid72.2M103.6M78.1M71.3M

Shanghai Rongtai cash flow statement Correlations

-0.260.080.51-0.280.610.180.07-0.460.32-0.14-0.730.060.010.49-0.28
-0.26-0.2-0.51-0.49-0.160.740.080.330.610.610.120.290.460.53-0.42
0.08-0.2-0.28-0.090.42-0.41-0.29-0.03-0.6-0.16-0.54-0.56-0.36-0.40.21
0.51-0.51-0.280.15-0.050.05-0.05-0.060.06-0.26-0.210.2-0.190.090.06
-0.28-0.49-0.090.15-0.06-0.550.2-0.44-0.370.150.12-0.66-0.71-0.720.72
0.61-0.160.42-0.05-0.06-0.260.08-0.760.030.05-0.65-0.320.020.110.28
0.180.74-0.410.05-0.55-0.260.220.330.850.54-0.090.50.360.81-0.72
0.070.08-0.29-0.050.20.080.22-0.480.40.63-0.24-0.16-0.260.2-0.24
-0.460.33-0.03-0.06-0.44-0.760.33-0.48-0.07-0.230.450.50.270.08-0.38
0.320.61-0.60.06-0.370.030.850.4-0.070.57-0.080.50.440.88-0.56
-0.140.61-0.16-0.260.150.050.540.63-0.230.57-0.22-0.24-0.190.24-0.07
-0.730.12-0.54-0.210.12-0.65-0.09-0.240.45-0.08-0.220.430.43-0.170.13
0.060.29-0.560.2-0.66-0.320.5-0.160.50.5-0.240.430.820.7-0.53
0.010.46-0.36-0.19-0.710.020.36-0.260.270.44-0.190.430.820.63-0.34
0.490.53-0.40.09-0.720.110.810.20.080.880.24-0.170.70.63-0.74
-0.28-0.420.210.060.720.28-0.72-0.24-0.38-0.56-0.070.13-0.53-0.34-0.74
Click cells to compare fundamentals

Shanghai Rongtai Account Relationship Matchups

Shanghai Rongtai cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(91.1M)(11.9M)(33.3M)71.0M55.0M57.8M
Other Cashflows From Financing Activities(97.6M)500K(44.8M)(1.9M)(1.8M)(1.8M)
Dividends Paid46.5M206.9M72.2M103.6M78.1M71.3M
Capital Expenditures161.4M190.1M141.5M100.7M89.6M103.2M
Total Cash From Operating Activities446.5M275.6M337.9M236.8M344.3M235.8M
Total Cash From Financing Activities(148.0M)(266.0M)357.8M(26.2M)(23.6M)(22.4M)
Other Cashflows From Investing Activities(6.5M)(28.2M)(13.9M)(12.0M)(10.8M)(11.3M)
Change To Account Receivables2.2M(60.3M)135.6M(115.7M)(104.1M)(98.9M)
Investments(225.8M)(412.4M)88.6M(128.8M)121.0M127.0M
Change In Cash(210.1M)6.8M229.2M220.5M49.1M46.6M
Net Borrowings(121.9M)564.3M110.5M293.1M337.1M354.0M
Total Cashflows From Investing Activities(395.6M)(597.3M)(65.3M)(225.0M)(202.5M)(212.7M)
Depreciation63.9M47.1M62.8M57.4M60.0M62.0M
Change To Operating Activities(5.6M)(215.8K)(11.1M)7.4M6.7M7.0M
Net Income295.6M193.0M236.3M164.2M202.7M176.4M
End Period Cash Flow873.2M880.1M1.1B1.3B1.4B1.1B
Change To Netincome(38.9M)35.6M2.1M10.3M9.3M9.7M
Change To Liabilities265.0M(161.7M)274.4M(129.5M)190.6M0.0
Free Cash Flow285.1M85.5M196.5M136.1M254.7M190.3M
Change In Working Capital121.3M5.7M41.6M(18.8M)47.2M49.5M
Begin Period Cash Flow1.1B873.2M880.1M1.1B1.3B1.1B
Other Non Cash Items6.9M40.9M52.2M18.5M28.5M32.3M

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

The Cash Flow Statement is a financial statement that shows how changes in Shanghai balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shanghai's non-liquid assets can be easily converted into cash.